Your position:www.healthoo.com >> EN >> EN >> Veterinary Drug >> Pfizer China Oncology Division Restructures Amid Executive Changes >> article
 
Pfizer China Oncology Division Restructures Amid Executive Changes
Editor:xuezhe     Clicks:8    Date:2025/3/21 11:48:52
Keyword: Pfizer
Healthoo Information:
Pfizer China Oncology Division Restructures Amid Executive Changes
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName 
Contact:  Title: Mr.Ms.
Password  
Repeat password: 
Mobile 
Email 
Verification code: 
Company Name 
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68012929
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Milli...
  • $36.781 Billion! "Drug King" Changed! "Cosmic Factory", Pfizer is Back...
  • China suspends Pfizer import of Fluconazole&n...
  • Pfizer and Hisun signed to build a ...
  • Hisun and Pfizer signed agreement to est...
  • Abbott to build nutritional plant in Chi...
  • Pfizer signed MOU with Hisun for joint&n...
  • Market activities of healthcare giants in&nbs...
  • Pfizer and MSD launched new dosage form&...
  • Ouyi Pharma to upgrade its Azithromycin ...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463